Ben Lamm, co-founder of Colossal Biosciences, has launched a new artificial intelligence company, Astromech, in partnership with Harvard geneticist George Church. SEC filings show the venture has already secured $30 million in funding.
Operating mainly in stealth mode, Astromech has released little information about its technology focus or operations. Lamm, who continues to lead Colossal Biosciences, expands his entrepreneurial portfolio with this new AI initiative.
Church, a world-renowned researcher in genetics and synthetic biology, brings decades of experience in genomics and biotechnology. His collaboration with Lamm builds on their existing partnership at Colossal Biosciences, the de-extinction company known for pioneering work in genetic restoration projects.
Financial documentation filed with the Securities and Exchange Commission reveals that Ben Lamm’s Astromech has completed a $30 million funding round. The company has been incorporated in Delaware, following standard practices for technology startups seeking venture capital investment.
Astromech maintains a low public profile.
About Ben Lamm
Ben Lamm brings experience from his role at Colossal Biosciences, where he has worked on complex biotechnology projects, including genetic restoration and de-extinction initiatives. Ben Lamm’s operational expertise in managing biotechnology ventures provides a foundation for his new AI-focused company.
The timing of Ben Lamm’s new venture reflects growing interest in artificial intelligence applications within the biotechnology and life sciences sectors, where computational tools are increasingly necessary for research and development activities.
For the latest updates, follow Ben Lamm on X.
